Clinical Trial Update: Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing an oral mercaptopurine suspension (100 mg/5 mL) with the tablet form in healthy male volunteers under fasted conditions; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Mercaptopurine (Mercaptopurine)

Snippet

Sponsor: Nova Laboratories Limited | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED